200 related articles for article (PubMed ID: 27317085)
21. Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm.
Ufer M; Rane A; Karlsson A; Kimland E; Bergman U
Eur J Clin Pharmacol; 2003 Mar; 58(11):779-83. PubMed ID: 12634986
[TBL] [Abstract][Full Text] [Related]
22. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].
García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C
An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379
[TBL] [Abstract][Full Text] [Related]
23. A survey of medicine use in children and adolescents in Austria.
Rauch E; Lagler FB; Herkner H; Gall W; Sauermann R; Hetz S; Male C
Eur J Pediatr; 2018 Oct; 177(10):1479-1487. PubMed ID: 29978258
[TBL] [Abstract][Full Text] [Related]
24. [Medicines for children and "off-label use" 5 years after implementation of the Paediatric Regulation (EC) No 1901/2006. An interim analyis].
Afentaki A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Sep; 57(9):1111-9. PubMed ID: 25139386
[TBL] [Abstract][Full Text] [Related]
25. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
[TBL] [Abstract][Full Text] [Related]
26. Respiratory drugs prescribed off-label among children in the outpatient clinics of a hospital in Malaysia.
Mohamad NF; Mhd Ali A; Mohamed Shah N
Int J Clin Pharm; 2015 Feb; 37(1):127-32. PubMed ID: 25488318
[TBL] [Abstract][Full Text] [Related]
27. Extemporaneous compounding in a sample of New Zealand hospitals: a retrospective survey.
Kairuz T; Chhim S; Hasan F; Kumar K; Lal A; Patel R; Singh R; Dogra M; Garg S
N Z Med J; 2007 Mar; 120(1251):U2466. PubMed ID: 17384694
[TBL] [Abstract][Full Text] [Related]
28. Paediatric drug use with focus on off-label prescriptions at Swedish hospitals - a nationwide study.
Kimland E; Nydert P; Odlind V; Böttiger Y; Lindemalm S
Acta Paediatr; 2012 Jul; 101(7):772-8. PubMed ID: 22404126
[TBL] [Abstract][Full Text] [Related]
29. Access to essential anticancer medicines for children and adolescents in Europe.
Vassal G; Kozhaeva O; Griskjane S; Arnold F; Nysom K; Basset L; Kameric L; Kienesberger A; Kamal S; Cherny N; Bricalli G; Latino N; Kearns P
Ann Oncol; 2021 Apr; 32(4):560-568. PubMed ID: 33388384
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial use in paediatric patients in a teaching hospital in Ethiopia.
Kebede HK; Gesesew HA; Woldehaimanot TE; Goro KK
PLoS One; 2017; 12(3):e0173290. PubMed ID: 28264021
[TBL] [Abstract][Full Text] [Related]
31. Unlicensed and off-label use of medicines at a neonatology clinic in Italy.
Dell'Aera M; Gasbarro AR; Padovano M; Laforgia N; Capodiferro D; Solarino B; Quaranta R; Dell'Erba AS
Pharm World Sci; 2007 Aug; 29(4):361-7. PubMed ID: 17351821
[TBL] [Abstract][Full Text] [Related]
32. Off-label and unlicenced medicine administration to paediatric emergency department patients.
McD Taylor D; Joffe P; Taylor SE; Jones A; Cheek JA; Craig SS; Graudins A; Dhir R; Krieser D; Babl FE
Emerg Med Australas; 2015 Oct; 27(5):440-6. PubMed ID: 26105103
[TBL] [Abstract][Full Text] [Related]
33. In-label and off-label use of respiratory drugs in the Italian paediatric population.
Baiardi P; Ceci A; Felisi M; Cantarutti L; Girotto S; Sturkenboom M; Baraldi E
Acta Paediatr; 2010 Apr; 99(4):544-9. PubMed ID: 20105140
[TBL] [Abstract][Full Text] [Related]
34. Access to Drugs and Out of Pocket Expenditure in Primary Health Facilities.
Thapa AK; Ghimire N; Adhikari SR
J Nepal Health Res Counc; 2016 Sep; 14(34):139-142. PubMed ID: 28327677
[TBL] [Abstract][Full Text] [Related]
35. Off label and unlicensed drugs use in paediatric cardiology.
Bajcetic M; Jelisavcic M; Mitrovic J; Divac N; Simeunovic S; Samardzic R; Gorodischer R
Eur J Clin Pharmacol; 2005 Nov; 61(10):775-9. PubMed ID: 16151762
[TBL] [Abstract][Full Text] [Related]
36. Antihistamines prescribed off-label among paediatric patients at a tertiary care hospital setting in Malaysia.
Tan RW; Mohamed Shah N
Int J Clin Pharm; 2016 Oct; 38(5):1277-85. PubMed ID: 27480982
[TBL] [Abstract][Full Text] [Related]
37. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic.
Schweigertova J; Durisova A; Dolnikova D; Ondriasova E; Balazova M; Slezakova V; Kuzelova M
Pediatr Int; 2016 Feb; 58(2):126-31. PubMed ID: 26256925
[TBL] [Abstract][Full Text] [Related]
38. Prescribed medicine use and extent of off-label use according to age in a nationwide sample of Australian children.
Schaffer AL; Bruno C; Buckley NA; Cairns R; Litchfield M; Paget S; Zoega H; Nassar N; Pearson SA
Paediatr Perinat Epidemiol; 2022 Sep; 36(5):726-737. PubMed ID: 35172017
[TBL] [Abstract][Full Text] [Related]
39. Frequency of dosage prescribing medication errors associated with manual prescriptions for very preterm infants.
Horri J; Cransac A; Quantin C; Abrahamowicz M; Ferdynus C; Sgro C; Robillard PY; Iacobelli S; Gouyon JB
J Clin Pharm Ther; 2014 Dec; 39(6):637-41. PubMed ID: 25060391
[TBL] [Abstract][Full Text] [Related]
40. The status of paediatric medicines initiatives around the world--What has happened and what has not?
Hoppu K; Anabwani G; Garcia-Bournissen F; Gazarian M; Kearns GL; Nakamura H; Peterson RG; Sri Ranganathan S; de Wildt SN
Eur J Clin Pharmacol; 2012 Jan; 68(1):1-10. PubMed ID: 21732178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
